GlassScriptPhysician profile
Andrea Dohlman
NPI 1255737359
$3,488.79
in general payments reported to CMS, 2019-2025
29 companies · $1,525 in 2025
The $1,525 reported for 2025 was more than what 89% of Adult Health (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $186).
See the full distribution for Adult Health (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $298 · 2022: $402 · 2023: $342 · 2024: $922 · 2025: $1,525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,715 · Education: $74.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,714.61 |
| Education | $74.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $757.94 | 2021-2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $292.16 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Tandem Diabetes Care, INC. | $284.04 | 2021-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $200.96 | 2023-2025 | Jardiance |
| Insulet Corporation | $189.09 | 2022-2024 | Omnipod |
| Medtronic, INC. | $187.54 | 2022-2025 | Minimed 780g |
| Lilly USA, LLC | $174.63 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Sanofi-Aventis U.S. LLC | $142.63 | 2024-2025 | |
| Corcept Therapeutics | $137.32 | 2024-2025 | Korlym |
| Cequr Corporation | $126.03 | 2024-2025 | Cequr Simplicity |
| Mannkind Corporation | $104.94 | 2025 | |
| Abbott Laboratories | $100.74 | 2021-2025 | Freestyle Libre 3 |
| Amgen INC. | $97.96 | 2024-2025 | Repatha, Evenity, Tepezza |
| Sequel Med Tech, LLC | $92.11 | 2025 | Twiist |
| Abbvie INC. | $88.27 | 2024-2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascendis Pharma Endocrinology INC | $79.13 | 2025 | Yorvipath, Skytrofa |
| Radius Health, INC. | $68.25 | 2024-2025 | Tymlos |
| Averitas Pharma INC. | $64.90 | 2024 | Qutenza |
| Recordati_rare_diseases_inc. | $56.11 | 2025 | Isturisa |
| Antares Pharma, INC. | $50.15 | 2024-2025 | Xyosted |
| Acella Pharmaceuticals, LLC | $36.70 | 2025 | NP Thyroid 60 |
| Neurocrine Biosciences, INC. | $26.63 | 2025 | |
| Chiesi USA, INC. | $26.21 | 2024 | Mycapssa |
| Ascensia Diabetes Care US INC. | $19.89 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.99 | 2023 | |
| Xeris Pharmaceuticals, INC. | $18.89 | 2025 | Gvoke Hypopen |
| Alexion Pharmaceuticals, INC. | $16.93 | 2025 | Strensiq |
| Currax Pharmaceuticals LLC | $16.51 | 2025 | Contrave |
| Boston Scientific Corporation | $13.14 | 2023 | Watchman Access System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Dohlman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.